David Viola
Ospedale Versilia · 99 works · 5,770 citations · h-index 35
Top works
- Association Between BRAF V600E Mutation and Mortality in Patients With Papillary Thyroid Cancer
- BRAFV600E Mutation and Outcome of Patients with Papillary Thyroid Carcinoma: A 15-Year Median Follow-Up Study
- Association Between BRAF V600E Mutation and Recurrence of Papillary Thyroid Cancer
- Prophylactic Central Compartment Lymph Node Dissection in Papillary Thyroid Carcinoma: Clinical Implications Derived From the First Prospective Randomized Controlled Single Institution Study
- TheBRAFV600E Mutation Is an Independent, Poor Prognostic Factor for the Outcome of Patients with Low-Risk Intrathyroid Papillary Thyroid Carcinoma: Single-Institution Results from a Large Cohort Study
- Differential Clinicopathological Risk and Prognosis of Major Papillary Thyroid Cancer Variants
- Genetic Landscape of Somatic Mutations in a Large Cohort of Sporadic Medullary Thyroid Carcinomas Studied by Next-Generation Targeted Sequencing
- Modifications in the Papillary Thyroid Cancer Gene Profile Over the Last 15 Years
- Abstracts
- Abstracts: 41st Annual Meeting of the European Thyroid Association
- Treatment of advanced thyroid cancer with targeted therapies: ten years of experience
- Active Surveillance in Papillary Thyroid Microcarcinomas is Feasible and Safe: Experience at a Single Italian Center
- Surgical Treatment of Low- and Intermediate-Risk Papillary Thyroid Cancer with Minimally Invasive Video-Assisted Thyroidectomy
- RET genetic screening of sporadic medullary thyroid cancer (MTC) allows the preclinical diagnosis of unsuspected gene carriers and the identification of a relevant percentage of hidden familial MTC (FMTC)
- Cabozantinib (XL184) for the Treatment of Locally Advanced or Metastatic Progressive Medullary Thyroid Cancer
- Patient Age–Associated Mortality Risk Is Differentiated by BRAF V600E Status in Papillary Thyroid Cancer
- Targeted Therapy in Thyroid Cancer: State of the Art
- The Prognostic Value of Tumor Multifocality in Clinical Outcomes of Papillary Thyroid Cancer
- Twenty-Five Years Experience on RET Genetic Screening on Hereditary MTC: An Update on The Prevalence of Germline RET Mutations
- New insights in the molecular signature of advanced medullary thyroid cancer: evidence of a bad outcome of cases with double RET mutations